New evidence demonstrates brain health support from daily caffeine.
For years, observational data have hinted at a relationship between coffee, tea, and cognitive function. Yet few studies have separated caffeinated from decaffeinated beverages or followed participants long enough to meaningfully assess dementia outcomes. A recent large scale prospective cohort analysis now provides one of the most comprehensive looks at this question to date.
Study Design: Four Decades of Follow-Up
This investigation pooled data from two landmark U.S. cohorts:
- 86,606 women from the Nurses’ Health Study (1980–2023)
- 45,215 men from the Health Professionals Follow-up Study (1986–2023)
Participants included were free of cancer, Parkinson’s disease, and dementia at baseline. Beverage intake, including caffeinated coffee, decaffeinated coffee, and tea, was assessed every 2–4 years using validated dietary questionnaires.
Outcomes Measured
Primary outcome
- Dementia diagnosed from a physician (confirmed via medical records and death certificates)
Secondary outcomes
- Subjective cognitive decline (self-reported)
- Objective cognitive performance (telephone-based neuropsychological testing in the NHS cohort)
Median follow-up approached 36.8 years, with some participants followed for up to 43 years. During that time, 11,033 dementia cases were identified.
What the Data Showed
Caffeinated Coffee
Compared to the lowest intake group, participants in the highest quartile of caffeinated coffee consumption had:
- 141 vs. 330 dementia cases per 100,000 person-years
- Hazard Ratio: 0.82 (95% CI: 0.76–0.89)
In addition:
- Lower prevalence of subjective cognitive decline
- Higher mean scores on objective cognitive testing
- A near significant association with global cognition (p=0.06)
Tea
Tea demonstrated similar inverse associations with dementia risk and cognitive decline, reinforcing the possibility that caffeine or related bioactive compounds may have a neuroprotective role.
Decaffeinated Coffee
Notably, decaffeinated coffee showed no significant association with lower dementia risk or improved cognitive performance.
Dose Matters: Moderate Intake Appears Optimal
The association followed a nonlinear, inverse pattern, with the greatest benefit seen at moderate levels of intake:
- 2–3 cups/day of caffeinated coffee, or
- 1–2 cups/day of tea
Higher consumption did not appear to confer additional benefit, reinforcing that more is not necessarily better.
Clinical Interpretation
For clinicians counseling patients on lifestyle factors and cognitive health, several practical points emerge:
- Moderate, habitual intake of caffeinated coffee or tea is associated with lower dementia risk.
- Cognitive performance measures show modest but consistent benefit.
- Decaffeinated coffee does not demonstrate the same association, suggesting caffeine or synergistic compounds may be contributory.
Importantly, these findings come from very well characterized cohorts of health professionals with repeated dietary measurements and decades long follow-up. This combination strengthens internal validity versus more short-term studies.
Caveats Worth Discussing
As with all observational data:
- Causality cannot be established.
- Residual confounding remains possible.
- The study population primarily consisted of healthcare professionals, which may limit generalizability.
Additionally, caffeine tolerance and contraindications should always be taken into consideration. For patients with poorly controlled hypertension, arrhythmias, anxiety disorders, or sleep disturbances, individual risk–benefit considerations are still necessary.
Practical Takeaway for Patient Counseling
For patients who already enjoy coffee or tea:
- There is no evidence-based reason to recommend discontinuation for cognitive health concerns.
- Moderate intake (2–3 cups coffee or 1–2 cups tea daily) appears reasonable and potentially protective.
In a field where modifiable dementia risk factors are limited, this data adds nuance to everyday clinical counseling. Sometimes, prevention may be less about adding a new supplement and more about refining the habits patients already have.
A daily cup may not be a cure. But for brain health, it may be more than just comfort.
Read the study: JAMA, 2026. Coffee and Tea Intake, Dementia Risk, and Cognitive Function.
Stay ahead of healthcare shifts, clinical innovation, and future of Pharmacy
